CryoPort Appoints Cindy Gick as Vice President of Client Care and Development; Plans New 24/7 Call Center Support
SAN DIEGO--(BUSINESS WIRE)-- CryoPort, Inc. (OTCBB: CYRX) today announced that it has named Cindy Gick as Vice President of Client Care and Development. Gick has more than 15 years of experience as a customer service executive and consultant. She will be responsible for the Company's new initiative to establish contact centers providing around-the-clock support and order entry service for customers worldwide.
"A key element of our growth strategy is to provide a level of customer support that meets the standard of our CryoPort Express Shipper and web portal ordering system," said Larry Stambaugh, CryoPort's Chairman and Chief Executive Officer. "Cindy Gick has designed and managed innovative, high quality programs for a number of successful companies. Because she has worked as a consultant, vendor and end-user, she understands how to integrate the technology, people and systems necessary to provide the best possible customer experience. We look forward to having our new 24/7 support service in place within 90 days."
Prior to joining CryoPort, Gick was a principal with CG Consulting Services, where she partnered with leading enterprises such as Allergan, Countrywide, Angels Baseball, FCG's Physician Referral/Nurse Triage Contact Center and Taco Bell Corporation to develop strategic direction, build strong customer relationships and high customer satisfaction focused on the "complete customer experience." Previously, she was a Director of First Consulting Group's (FCG) Call Center, CRM, and Telecom Practice, and a Director of Call Center Technology for Viking Office Products.
CryoPort has partnered with PFITECH to help build the infrastructure for its call centers, which will initially be placed in California, Hawaii and the Philippines. PFITECH is a leading provider of information technology and custom business process solutions with an emphasis on logistics and supply chain management.
About CryoPort, Inc.
CryoPort (www.cryoport.com) has developed a leading edge, proprietary, technology-driven transport and packaging system focused on providing a solution that replaces dry ice for the frozen shipping market in the growing global life science industry. The products developed by CryoPort have a 10+ day holding time, are using "green" materials and are essential components of the infrastructure required for the testing, research and end-user delivery of temperature-sensitive medicines and biomaterials in an increasingly complex global logistical environment.
Forward Looking Statements
Statements in this press release which are not purely historical, including statements regarding CryoPort, Inc.'s intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. It is important to note that the company's actual results could differ materially from those in any such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, risks and uncertainties associated with the effect of changing economic conditions, trends in the products markets, variations in the company's cash flow, market acceptance risks, and technical development risks. The company's business could be affected by a number of other factors, including the risk factors listed from time to time in the company's SEC reports including, but not limited to, the annual report on Form 10-K for the year ended March 31, 2010. The company cautions investors not to place undue reliance on the forward-looking statements contained in this press release. CryoPort, Inc. disclaims any obligation, and does not undertake to update or revise any forward-looking statements in this press release.
Source: CryoPort, Inc.
Released April 12, 2011